Shakya; Sagar Raj

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shakya; Sagar Raj.The latest application filed is for "crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disorders".

Company Profile

3.3.5

Shakya; Sagar Raj - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders App 20220002244 - Blackburn; Anthony C. ; et al.	2022-01-06
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P.sub.1 receptor-associated disorders Grant 11,091,435 - Blackburn , et al. August 17, 2	2021-08-17
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders App 20200361869 - Blackburn; Anthony C. ; et al.	2020-11-19
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders Grant 10,676,435 - Blackburn , et al.	2020-06-09
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3- App 20190330153 - Blackburn; Anthony C. ; et al.	2019-10-31
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders Grant 10,301,262 - Blackburn , et al.	2019-05-28
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders App 20180186738 - Blackburn; Anthony C. ; et al.	2018-07-05
Crystalline Forms And Processes For The Preparation Of Pg12 Receptor Agonists App 20120225937 - Blackburn; Anthony C. ; et al.	2012-09-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.